Drug Type Small molecule drug |
Synonyms NCE Ox1, Ox-1 |
Target |
Action antagonists |
Mechanism OX1R antagonists(Orexin receptor type 1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Binge-Eating Disorder | Preclinical | United Kingdom | 01 May 2025 | |
Substance-Related Disorders | Preclinical | United Kingdom | 01 May 2025 | |
Anxiety Disorders | Preclinical | United Kingdom | 06 May 2024 |